Triple
T15982938
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ariad Pharmaceuticals |
E387618
|
entity |
| Predicate | ponatinibIndication |
P113308
|
FINISHED |
| Object | chronic myeloid leukemia |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: chronic myeloid leukemia | Statement: [Ariad Pharmaceuticals, ponatinibIndication, chronic myeloid leukemia]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: ponatinibIndication Context triple: [Ariad Pharmaceuticals, ponatinibIndication, chronic myeloid leukemia]
-
A.
treatmentIndication
chosen
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
B.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
C.
hasTargetDisease
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
-
D.
indicatedFor
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
-
E.
isPegylated
Indicates that a molecule, typically a drug or therapeutic agent, has been chemically modified by the attachment of polyethylene glycol (PEG) chains.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d86da94ccc819083d187f5dc6a123e |
completed | April 10, 2026, 3:25 a.m. |
| NER | Named-entity recognition | batch_69e17d4d08f481909f38b75e3f42d9ab |
completed | April 17, 2026, 12:22 a.m. |
| PD | Predicate disambiguation | batch_69e142d9d8e881909b559a3e3ca21d24 |
completed | April 16, 2026, 8:13 p.m. |
Created at: April 10, 2026, 4:54 a.m.